SE0001330L - Novel method of treatment - Google Patents

Novel method of treatment

Info

Publication number: SE0001330L
Authority: SE; Sweden
Prior art keywords: treatment; novel method; amoxycillin; treated; image
Prior art date: 1999-04-13

Application number

SE0001330A

Other languages

English (en)

Swedish (sv)

Other versions

SE0001330D0 (sv

Inventor

Kevin Storm

Creighton Conley

John Roush

Original Assignee

Beecham Pharm Pte Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-13

Filing date

2000-04-11

Publication date

2000-10-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0001330(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-11 Application filed by Beecham Pharm Pte Ltd filed Critical Beecham Pharm Pte Ltd

2000-04-11 Publication of SE0001330D0 publication Critical patent/SE0001330D0/xx

2000-10-14 Publication of SE0001330L publication Critical patent/SE0001330L/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Peptides Or Proteins (AREA)

SE0001330A 1999-04-13 2000-04-11 Novel method of treatment SE0001330L (sv)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US12907499P	1999-04-13	1999-04-13
US15072799P	1999-08-25	1999-08-25
US15981399P	1999-10-15	1999-10-15

Publications (2)

Publication Number	Publication Date
SE0001330D0 SE0001330D0 (sv)	2000-04-11
SE0001330L true SE0001330L (sv)	2000-10-14

Family

ID=27383840

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0001330A SE0001330L (sv)	1999-04-13	2000-04-11	Novel method of treatment

Country Status (44)

Country	Link
EP (4)	EP1269997A1 (fr)
JP (2)	JP4880125B2 (fr)
KR (1)	KR100634937B1 (fr)
CN (1)	CN100382782C (fr)
AP (1)	AP1806A (fr)
AR (1)	AR031068A1 (fr)
AT (2)	ATE242629T1 (fr)
AU (1)	AU767177B2 (fr)
BE (2)	BE1013309A5 (fr)
BG (1)	BG65006B1 (fr)
BR (1)	BRPI0009719B8 (fr)
CA (1)	CA2366304C (fr)
CO (1)	CO5170471A1 (fr)
CZ (1)	CZ298801B6 (fr)
DE (3)	DE60003255T2 (fr)
DK (3)	DK200000602A (fr)
DZ (1)	DZ3150A1 (fr)
EA (1)	EA004310B1 (fr)
ES (2)	ES2190692B1 (fr)
FI (2)	FI4823U1 (fr)
FR (1)	FR2792198A1 (fr)
GB (1)	GB2351661B (fr)
GR (1)	GR1003560B (fr)
HU (1)	HU229097B1 (fr)
IE (1)	IE20000271A1 (fr)
IL (2)	IL145580A0 (fr)
IT (1)	ITMI20000788A1 (fr)
MA (1)	MA25352A1 (fr)
MX (1)	MXPA01010377A (fr)
MY (1)	MY119953A (fr)
NL (2)	NL1014914C1 (fr)
NO (1)	NO329694B1 (fr)
NZ (1)	NZ514575A (fr)
OA (1)	OA11926A (fr)
PE (1)	PE20010053A1 (fr)
PL (1)	PL197448B1 (fr)
PT (2)	PT1044680E (fr)
RO (1)	RO120817B1 (fr)
SE (1)	SE0001330L (fr)
SI (2)	SI20304A (fr)
SK (1)	SK285140B6 (fr)
TR (1)	TR200102963T2 (fr)
TW (1)	TWI235067B (fr)
WO (1)	WO2000061116A2 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
DK0862431T3 (da)	1995-09-07	2002-03-11	Smithkline Beecham Plc	Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
SE9802973D0 (sv)	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
AU2001292185A1 (en)	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US20030035839A1 (en) *	2001-05-15	2003-02-20	Peirce Management, Llc	Pharmaceutical composition for both intraoral and oral administration
KR20030034171A (ko)	2001-07-06	2003-05-01	엔도 파마슈티걸즈, 인크.	옥시모르폰 제어 방출 제형
GB0117618D0 (en) *	2001-07-19	2001-09-12	Phoqus Ltd	Pharmaceutical dosage form
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en)	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
JP4732696B2 (ja)	2002-04-09	2011-07-27	フラメル・テクノロジー	活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
WO2003086267A2 (fr) *	2002-04-10	2003-10-23	Miller Fred H	Systeme capsulaire a plusieurs compartiments et plusieurs phases
US20050042289A1 (en) *	2003-04-29	2005-02-24	Yamanouchi Pharma Technologies, Inc.	Tablets and methods for modified release of hydrophylic and other active agents
AU2004264356B2 (en)	2003-08-12	2011-01-27	Shionogi, Inc.	Antibiotic product, use and formulation thereof
EP1541129A1 (fr) *	2003-12-12	2005-06-15	Cimex AG	Composition effervescente pharmaceutique contenant de l'amoxicilline et du clavulanate
WO2005079752A2 (fr) *	2004-02-11	2005-09-01	Rubicon Research Private Limited	Compositions pharmaceutiques a liberation controlee presentant une meilleure biodisponibilite
WO2005099672A1 (fr) *	2004-04-13	2005-10-27	Ranbaxy Laboratories Limited	Formulation pharmaceutique a liberation modifiee contenant de l'amoxicilline et du clavulanate
EP1880716A1 (fr) *	2006-07-19	2008-01-23	Sandoz AG	Kit comprenant un produit actif métastable à l'acide et un produit actif stable à l'acide
EP2079453A1 (fr) *	2006-10-10	2009-07-22	Penwest Pharmaceuticals Co.	Formulations robustes à libération prolongée
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
WO2016164464A1 (fr) *	2015-04-07	2016-10-13	Church & Dwight Co., Inc.	Compositions gommeuses à plusieurs composants à noyau dur
CN109394718B (zh) *	2018-11-15	2021-04-27	石药集团中诺药业（石家庄）有限公司	一种阿莫西林分散片及其制备方法
CN110051637A (zh) *	2019-05-21	2019-07-26	葵花药业集团北京药物研究院有限公司	阿莫西林克拉维酸钾制剂及其制备方法
JP7845721B2 (ja) *	2022-04-29	2026-04-14	オーバーシーズファーマシューティカルズリミテッド	ピルフェニドンの経口用持続放出性固形製剤

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0008905B1 (fr) *	1978-09-06	1983-02-16	Beecham Group Plc	Compositions pharmaceutiques contenant deux dérivés de bêta-lactame
IL58461A0 (en) *	1978-10-27	1980-01-31	Beecham Group Ltd	Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) *	1979-12-07	1981-06-12	Panoz Donald	Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) *	1990-04-07	1990-06-06	Beecham Group Plc	Pharmaceutical formulation
GB9109862D0 (en) *	1991-05-08	1991-07-03	Beecham Lab Sa	Pharmaceutical formulations
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
EP1034784A3 (fr) *	1993-01-22	2001-06-27	Smithkline Beecham Plc	Formulations pharmaceutique contenant d'acide clavulanique et un agent antibacterien
GB9311030D0 (en) *	1993-05-28	1993-07-14	Smithkline Beecham Corp	Pharmaceutical formulations
IL109770A0 (en) *	1993-05-29	1994-11-28	Smithkline Beecham Corp	Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
GB9407386D0 (en) *	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
ITMI941169A1 (it) *	1994-06-06	1995-12-06	Smithkline Beecham Farma	Formulazioni farmaceutiche
GB9416599D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
GB9416600D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
DK0862431T3 (da) *	1995-09-07	2002-03-11	Smithkline Beecham Plc	Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
GB9616536D0 (en) *	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
SK110299A3 (en) *	1997-02-14	2000-08-14	Smithkline Beecham Lab	Pharmaceutical formulations comprising amoxocyllin and clavulanate, preparation method and use thereof
SK121099A3 (en) *	1997-03-11	2000-06-12	Almag Al	Process and apparatus for coating metals
SE9700885D0 (sv) *	1997-03-12	1997-03-12	Astra Ab	New pharmaceutical formulation
ATE286715T1 (de) *	1997-03-25	2005-01-15	Takeda Chemical Industries Ltd	Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
JP3746901B2 (ja) *	1997-10-15	2006-02-22	ユニ・チャーム株式会社	開閉自在容器
GB9815532D0 (en) *	1998-07-17	1998-09-16	Lek Pharmaceutical & Cvhemical	Pharmaceutical suspension formulation
GB9818927D0 (en) *	1998-08-28	1998-10-21	Smithkline Beecham Plc	Pharmaceutical formulation
US6225304B1 (en) *	1999-02-17	2001-05-01	Pharmaceutical Solutions, Inc.	Soluble forms of amoxicillin and treatment of animals

2000
- 2000-04-11 IL IL14558000A patent/IL145580A0/xx active IP Right Grant
- 2000-04-11 PT PT00303033T patent/PT1044680E/pt unknown
- 2000-04-11 AR ARP000101657A patent/AR031068A1/es not_active Application Discontinuation
- 2000-04-11 SK SK534-2000A patent/SK285140B6/sk not_active IP Right Cessation
- 2000-04-11 MY MYPI20001509A patent/MY119953A/en unknown
- 2000-04-11 WO PCT/IB2000/000992 patent/WO2000061116A2/fr not_active Ceased
- 2000-04-11 CZ CZ20001311A patent/CZ298801B6/cs not_active IP Right Cessation
- 2000-04-11 ES ES200000935A patent/ES2190692B1/es not_active Withdrawn - After Issue
- 2000-04-11 IT IT2000MI000788A patent/ITMI20000788A1/it unknown
- 2000-04-11 SE SE0001330A patent/SE0001330L/xx not_active Application Discontinuation
- 2000-04-11 EP EP02078928A patent/EP1269997A1/fr not_active Withdrawn
- 2000-04-11 TW TW089106937A patent/TWI235067B/zh not_active IP Right Cessation
- 2000-04-11 SI SI200000097A patent/SI20304A/sl not_active IP Right Cessation
- 2000-04-11 DZ DZ003150A patent/DZ3150A1/fr active
- 2000-04-11 PT PT102450A patent/PT102450B/pt active IP Right Grant
- 2000-04-11 NZ NZ514575A patent/NZ514575A/en not_active IP Right Cessation
- 2000-04-11 CA CA002366304A patent/CA2366304C/fr not_active Expired - Lifetime
- 2000-04-11 AT AT00303033T patent/ATE242629T1/de active
- 2000-04-11 HU HU0001471A patent/HU229097B1/hu unknown
- 2000-04-11 CO CO00026419A patent/CO5170471A1/es not_active Application Discontinuation
- 2000-04-11 DK DK200000602A patent/DK200000602A/da not_active Application Discontinuation
- 2000-04-11 EP EP02078926A patent/EP1269996A1/fr not_active Withdrawn
- 2000-04-11 BE BE2000/0255A patent/BE1013309A5/fr not_active IP Right Cessation
- 2000-04-11 EP EP02078927A patent/EP1270005A3/fr not_active Withdrawn
- 2000-04-11 PE PE2000000332A patent/PE20010053A1/es not_active Application Discontinuation
- 2000-04-11 NL NL1014914A patent/NL1014914C1/nl not_active IP Right Cessation
- 2000-04-11 DE DE60003255T patent/DE60003255T2/de not_active Expired - Lifetime
- 2000-04-11 KR KR1020017012988A patent/KR100634937B1/ko not_active Expired - Fee Related
- 2000-04-11 RO ROA200000399A patent/RO120817B1/ro unknown
- 2000-04-11 FI FI20000164U patent/FI4823U1/fi active
- 2000-04-11 EP EP00303033A patent/EP1044680B1/fr not_active Expired - Lifetime
- 2000-04-11 FR FR0004631A patent/FR2792198A1/fr active Pending
- 2000-04-11 ES ES00303033T patent/ES2202004T3/es not_active Expired - Lifetime
- 2000-04-11 MX MXPA01010377A patent/MXPA01010377A/es active IP Right Grant
- 2000-04-11 TR TR2001/02963T patent/TR200102963T2/xx unknown
- 2000-04-11 DE DE20006626U patent/DE20006626U1/de not_active Expired - Lifetime
- 2000-04-11 NL NL1014915A patent/NL1014915C2/nl not_active IP Right Cessation
- 2000-04-11 GB GB0008923A patent/GB2351661B/en not_active Revoked
- 2000-04-11 AT AT0027900U patent/AT4327U1/de not_active IP Right Cessation
- 2000-04-11 AU AU57020/00A patent/AU767177B2/en not_active Expired
- 2000-04-11 FI FI20000863A patent/FI20000863L/fi unknown
- 2000-04-11 GR GR20000100122A patent/GR1003560B/el unknown
- 2000-04-11 OA OA1200100257A patent/OA11926A/en unknown
- 2000-04-11 DE DE10017883A patent/DE10017883A1/de not_active Withdrawn
- 2000-04-11 BR BRPI0009719A patent/BRPI0009719B8/pt not_active IP Right Cessation
- 2000-04-11 EA EA200101075A patent/EA004310B1/ru not_active IP Right Cessation
- 2000-04-11 DK DK00303033T patent/DK1044680T3/da active
- 2000-04-11 AP APAP/P/2001/002284A patent/AP1806A/en active
- 2000-04-11 IE IE20000271A patent/IE20000271A1/en not_active IP Right Cessation
- 2000-04-11 PL PL339591A patent/PL197448B1/pl unknown
- 2000-04-11 DK DK200000133U patent/DK200000133U3/da not_active IP Right Cessation
- 2000-04-11 JP JP2000610449A patent/JP4880125B2/ja not_active Expired - Lifetime
- 2000-04-11 BG BG104329A patent/BG65006B1/bg unknown
- 2000-04-11 NO NO20001870A patent/NO329694B1/no not_active IP Right Cessation
- 2000-04-11 BE BE00/0256A patent/BE1012733A6/fr not_active IP Right Cessation
- 2000-04-11 CN CNB008086737A patent/CN100382782C/zh not_active Expired - Lifetime
- 2000-04-11 SI SI200030183T patent/SI1044680T1/xx unknown
2001
- 2001-09-24 IL IL145580A patent/IL145580A/en not_active IP Right Cessation
- 2001-10-12 MA MA26356A patent/MA25352A1/fr unknown
2011
- 2011-07-22 JP JP2011161132A patent/JP2011256180A/ja active Pending

Also Published As

Publication number	Publication date
PT102450A (pt)	2001-02-01
SE0001330D0 (sv)	2000-04-11
AT4327U1 (de)	2001-06-25
NL1014915A1 (nl)	2000-10-16
MY119953A (en)	2005-08-30
CO5170471A1 (es)	2002-06-27
BR0009719A (pt)	2002-01-08
TR200102963T2 (tr)	2002-02-21
SI20304A (sl)	2001-02-28
FIU20000164U0 (fi)	2000-04-11
BE1012733A6 (fr)	2001-02-06
EP1044680B1 (fr)	2003-06-11
WO2000061116A2 (fr)	2000-10-19
NO20001870L (no)	2000-10-16
ITMI20000788A1 (it)	2001-10-11
EA200101075A1 (ru)	2002-04-25
DK200000602A (da)	2000-10-14
IL145580A0 (en)	2002-11-10
NO329694B1 (no)	2010-12-06
NZ514575A (en)	2004-05-28
CZ298801B6 (cs)	2008-02-06
HU0001471D0 (en)	2000-06-28
JP4880125B2 (ja)	2012-02-22
EP1270005A2 (fr)	2003-01-02
IL145580A (en)	2007-05-15
DE10017883A1 (de)	2000-10-26
HUP0001471A3 (en)	2001-10-29
JP2002541187A (ja)	2002-12-03
PT102450B (pt)	2003-09-30
ES2190692B1 (es)	2004-11-16
GB2351661B (en)	2001-10-10
SK5342000A3 (en)	2000-11-07
AR031068A1 (es)	2003-09-10
DK1044680T3 (da)	2003-09-29
RO120817B1 (ro)	2006-08-30
FI20000863A7 (fi)	2000-10-13
KR20020015312A (ko)	2002-02-27
DZ3150A1 (fr)	2000-10-19
CN100382782C (zh)	2008-04-23
WO2000061116A3 (fr)	2001-02-01
BG104329A (en)	2001-11-30
HU229097B1 (en)	2013-07-29
CN1382040A (zh)	2002-11-27
EP1269996A1 (fr)	2003-01-02
CA2366304A1 (fr)	2000-10-19
GB2351661A (en)	2001-01-10
ATE242629T1 (de)	2003-06-15
ES2190692A1 (es)	2003-08-01
EP1270005A3 (fr)	2006-05-17
BG65006B1 (bg)	2006-12-29
AU767177B2 (en)	2003-11-06
BRPI0009719B8 (pt)	2021-05-25
PT1044680E (pt)	2003-10-31
NL1014914C1 (nl)	2000-10-16
FI20000863A0 (fi)	2000-04-11
NO20001870D0 (no)	2000-04-11
PL339591A1 (en)	2000-10-23
DE20006626U1 (de)	2000-10-19
MXPA01010377A (es)	2002-10-23
CA2366304C (fr)	2004-06-29
PE20010053A1 (es)	2001-03-10
IE20000271A1 (en)	2001-04-04
DE60003255D1 (de)	2003-07-17
AP1806A (en)	2007-12-14
SI1044680T1 (en)	2003-12-31
FR2792198A1 (fr)	2000-10-20
TWI235067B (en)	2005-07-01
AU5702000A (en)	2000-11-14
FI20000863L (fi)	2000-10-13
EA004310B1 (ru)	2004-02-26
NL1014915C2 (nl)	2001-02-12
EP1269997A1 (fr)	2003-01-02
OA11926A (en)	2006-04-12
DE60003255T2 (de)	2004-05-06
EP1044680A1 (fr)	2000-10-18
KR100634937B1 (ko)	2006-10-17
HK1032741A1 (en)	2001-08-03
DK200000133U3 (da)	2000-07-28
HUP0001471A2 (en)	2001-03-28
GR1003560B (el)	2001-03-16
CZ20001311A3 (cs)	2000-11-15
MA25352A1 (fr)	2001-12-31
ITMI20000788A0 (it)	2000-04-11
AP2001002284A0 (en)	2001-12-31
GB0008923D0 (en)	2000-05-31
BE1013309A5 (fr)	2001-11-06
BR0009719B1 (pt)	2014-09-30
FI4823U1 (fi)	2001-02-16
JP2011256180A (ja)	2011-12-22
ES2202004T3 (es)	2004-04-01
PL197448B1 (pl)	2008-03-31
SK285140B6 (sk)	2006-07-07

Legal Events

Date	Code	Title	Description
2004-02-03	NAV	Patent application has lapsed

Publication	Publication Date	Title
SE0001330D0 (sv)	2000-04-11	Novel method of treatment
HK1045101A1 (zh)	2002-11-15	含有羟氨苄青霉素的药学配方
CO4560547A1 (es)	1998-02-10	Una forma de dosis de azitromicina y un metodo de trata- miento de una infeccion microbiana que involucra la adminis- tracion de azitromicina
DK0871465T3 (da)	2003-02-03	Anvendelse af ritonavir (ABT-538) til at forbedre farmakokinetikken af lægemidler, som metaboliseres af cytochrom P450, i en metode til behandling af AIDS
LU91928I2 (fr)	2012-03-09	Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
ES2180251T3 (es)	2003-02-01	Comprimido revestido con polimero, que contiene amoxicilina y clavulanato.
ATE300977T1 (de)	2005-08-15	Apparat zur verhütung von infektionen
MX9708627A (es)	1998-02-28	Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas.
DE60123276D1 (de)	2006-11-02	Piperazinderivate zur behandlung bakterieller infektionen
DK0742722T3 (da)	2002-06-17	Fremgangsmåde til at forøge biotilgængeligheden af orale farmaceutiske præparater
NL300128I1 (nl)	2003-07-01	Gesubstitueerde isoxyzolen voor de behandeling vanontsteking.
NO993887L (no)	1999-08-12	Farmasöytiske formuleringer som innbefatter amoksycillin og clavulanat
RU94035686A (ru)	1996-09-10	4-ариламино-бензопиран и родственные соединения, фармацевтическая композиция, способ лечения
AU6563596A (en)	1997-03-20	Treatment of tinnitis using neuroprotective agents
DK0748387T3 (da)	1998-05-25	Fremgangsmåde til isolation af clavulansyre og farmaceutisk acceptable salte deraf fra fermenteringsvæsken af Streptomyces sp. P 6621 FERM P 2804
WO2001074788A8 (fr)	2001-12-20	Dérivés de 2-(s)-hydroxymutiline carbamate pour utilisation antibactérienne
DE69430385D1 (de)	2002-05-16	Hiv-proteaseinhibitoren
AU2002332488A1 (en)	2004-02-25	R-bambuterol, its preparation and therapeutic uses
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner
ECSP003432A (es)	2000-07-21	Nuevo metodo de tratamiento
UY26104A1 (es)	2000-10-31	Nuevo metodo de tratamiento.
NO890287D0 (no)	1989-01-23	Fremstilling av beta-laktam-antibiotika.
SE9602145D0 (sv)	1996-05-31	New improved formulation for treatment of thromboembolism
ECSP961736A (es)	1997-10-03	Metodo de tratamiento
PA8505301A1 (es)	2002-12-30	Metodo para tratar el mal de parkinson a traves de la administracion de ( - ) - 5 ceto-2-n- propilamino - tetrahidrotetralina